Approved Study Database

Ref. No. Scientific Title Principal investigator
2005.110 A Randomized, Double-blind, Two-arms Placebo-controlled, Parallel-group, Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdoninally Obese Patients Prof. Brian Tomlinson
2006.345 A Pilot Study to Investigate the Efficacy and Safety of IMD-1041 in Patients With Type II Diabetes Mellitus Prof. Brian Tomlinson
2003.178 Safety, Viremia, and Immunogenicity of Low -(10-2 TCID-50) and High- (10-4 TCID-50) Virus Concentration Monovalent Vero Dengue-3 Vaccine Versus Stamaril® (Aventis Pasteur Yellow Fever Vaccine) in Flavivirus Na_ve Healthy Adults Prof. Brian Tomlinson
2007.308 Multi-Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of DU-176b in Chinese Healthy Male Adult Subjects Prof. Briant Tomlinson
2006.190 Targeting Apoptosis: A Study of Laser Indcution and Hyaluronan Modulation in Keloid Derived Cells BURD Andrew
2007.202 Stem Cell Strategies in Burns Care: Human Umbilical Cord Blood and Cord Lining Cells BURD Andrew
2006.284 Assessing Facial Function in Chinese Patients with Facial Burns: The Facial Functional Impairment Index BURD Andrew
2006.434 An Investigation of the Potential Therapeutic Application of Human Umbilical Cord Lining Epithelium for the Reconstruction of the Skin and Buccal Mucosal Epithelial Defects BURD Andrew
2004.162 An Investigation of the Role of Epidermal Stem Cells in Modulating Epithelial-Mesenchymal Networks in Post-burn Keloid Scarring BURD Andrew
2010.363 Psychiatric Morbidity in Chinese Adult Burn Survivors in a Tertiary Burns Unit BURD Andrew
2004.433 An Evaluation of Foetal Stem Cell Interactions with Post Natal Keratinocytes and Dermal Fibroblasts BURD Andrew
2008.178 An Investigation of the Plasticity of Human Umbilical Cord Lining for Epithelial Reconstitution BURD Andrew
2003.286 Quality of Life, Cost Effectiveness, Survival and Functional Outcomes Following Differential Management of Laryngeal Cancer Prof. C.A. Van Hasselt
2008.291 Derivation and Validation of a Clinical Decision Rule for Identifying Critically Ill Patients in the Emergency Department CATTERMOLE Giles
2005.438 Health Related Quality of Life of Pacemaker Patients in Hong Kong CHAIR Sek Ying
2006.399 The Effect of Motivational Interviewing on the Clinical Outcomes, Psychological Outcomes and Health-related Quality of Life of Cardiac, Rehabilitation Clients with Poor Motivation CHAIR Sek Ying
2006.086 The Effect of Motivational Interviewing on the Clinical Outcomes, Psychological Outcomes and Health-related Quality of Life of Clients Receiving Cardiac Rehabilitation CHAIR Sek Ying
2003.219 LY582563 and Lamivudine Interaction Study in Lamivudine-Resistant Hepatitis B Virus(HBV) Patients Prof. Chan Lik Yuen Henry
2004.248 Biweekly Gemcitabine and Oxaliplatin (GEMOX) in First-line Metastatic or Recurrent Nasopharyngeal Carcinoma (NPC) Prof. Chan Anthony
2003.372 A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Carcinoma Prof. Chan Anthony
2004.447 Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine (SR259075) Versus Concomitant Radiation and Cisplatin in Patients with Advanced Head and Neck Cancer Prof. Chan Anthony
2007.098 A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Heart and Neck Prof. Chan Anthony
2004.055 Molecular Characterization of Putative Oncogenes in Medulloblastoma CHAN Bik Wan Amy
2009.567 The protein components of nodular glomerulosclerosis in diabetic nephropathy CHAN C.N. Juliana
2003.356 CS-866 DM (Olmesartan) Phase III Study: A Double-blind, Placebo-Controlled Trial in Patients with Diabetic Nephropathy and Overt Proteinuria Secondary to Type 2 Diabetes Prof. Chan C.N. Juliana
2004.183 A 52-Week Randomized, Double-blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Administered to Patients with Type 2 Diabetes Prof. Chan C.N. Juliana
2005.138 International Diabetes Management Practices Study, The Prof. Chan C.N. Juliana
2005.254 A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar Therapy in Patients with Type 2 Diabetes Mellitus (GALLEX 4) Prof. Chan C.N. Juliana
2002.468 "A Multicentre, Double-Blind, Ranomized, Placebo-and Active-Controlled, Parallel Study to Evaluate the Glucose and Lipid-Altering Efficacy and Safety of L-410198 in Patients with Type 2 Diabetes" and An Extension to : "A Multicentre, Double-Blind, Ranomized, Placebo-and Active-Controlled, Parallel Study to Evaluate the Glucose and Lipid-Altering Efficacy and Safety of L-410198 in Patients with Type 2 Diabetes" Prof. Chan C.N. Juliana
2005.255 A Long-Term, Post Treatment, Safety Follow-up, Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies G-PLUS (GALLANT, GALLEX and ARMOR Prof. Chan C.N. Juliana
2004.182 A 24-Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Extended Release AVANDIA_ (8mg OD) and Immediate-Release AVANDIA (8mg OD) in Subjects with Type 2 Diabetes Mellitus Prof. Chan C.N. Juliana
2004.387 The Impact of Assistive Technology on the Community Particiation and Quality of Life of People with Spinal Cord Injury CHAN Chi Chung Sam
2006.270 ONTARGET and TRANSCEND Study (Protocol No. 502.373) CHAN Chi Kin Hamish
2007.372 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of A Single Treatment with Two Dose Levels of BOTOXョ (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed By A Treatment with BOTOXョ in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Prof. Chan Chi Kwok
2009.390 Laboratory study of the intestional distribution of human influenza virus receptor using archived, formalin-fixed paraffin-embedded human duodenal tissue blocks CHAN Chi Wai
2013.527 Predictive value of EGFR mutation to whole brain radiotherapy (WBRT) in patients with non-small cell lung cancer (NSCLC) brain metastasis (BM) CHAN Chiu Yan
2006.174 Epidemiological Analysis and Estabishment of a DNA Fingerprinting Database of Multiple-Drug-Resistant Mycobacterium Tuberculosis Clinical Isolates in Hong Kong CHAN Chiu Yeung Raphael
2003.310 The Development and Testing of an Instrument for Measuring Awareness of Coronary Heart Disease in a Chinese Population CHAN Choi Wan (No email address)
2006.266 Non-compliance of Hip Protectors in Elderly CHAN Chung Man Barbara
2004.227 A Multicenter Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK-0431 Monotherapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control Prof. Chan Chung Ngor Juliana
2004.226 A Multicentre, Randomized Study to Examine the Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients with Nephropathy Prof. Chan Chung Ngor Juliana
2010.353 Evaluation of the Efficacy of an insulin Initiation Program on Self-Management Behavior, Psychosocial Measures and Metabolic Control in Chinese Patients with Type 2 Diabetes CHAN Chung Ngor Juliana
2011.451 Using SUDOSCAN to develop a clinical score a detect and predict diabetic kidney disease CHAN Chung Ngor Juliana
2010.352 Evaluation of the Effectiveness of a Patient Diabetes Education Program on Diabetes Knowledge, Behavioral, Psychosocial and Metabolic Measures in Chinese Patients with Type 2 Diabetes CHAN Chung Ngor Juliana
2005.238 A Controlled Study of Family Dynamics and Adolescent Obesity in Hong Kong CHAN CN Juliana
2004.418 A Multidisciplinary Project to Identify Major Genes for Diabetes and Metabolic Syndrome in Chinese and to Assess its Functional Significance CHAN CN Juliana
2005.116 Association between Chronic Hepatitis B Viral Infection, Hyperglycemia and Insulin Resistance in Hong Kong Chinese CHAN CN Juliana
2004.417 Development of a Statistical Model to Predict Risk and Assess Effects of Targeted Treatment on Diabetic Complications Using A Diabetes Registry CHAN CN Juliana
2006.043 The Amylin Gene Mutations and Islet Amyloid in Type 2 Diabetes Mellitus CHAN CN Juliana
2005.365 An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1mg in Patients with Type 2 Diabetes Mellitus (GALLEX 1) Prof. Chan CN Juliana

Page 2 of 253.